NCT04328012View on ClinicalTrials.gov

COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 6, 2020

Primary Completion Date

July 1, 2021

Study Completion Date

December 1, 2021

Conditions
SARS-CoV-2 Infection
Interventions
DRUG

Losartan

administered 14 days

DRUG

Placebo

administered 14 days

Trial Locations (1)

13326

Bassett Medical Center, Cooperstown

Sponsors

Lead Sponsor

Bassett Healthcare
All Listed Sponsors
collaborator

Reid Health

UNKNOWN

collaborator

Goshen Health System

OTHER

lead

Bassett Healthcare

OTHER

NCT04328012 - COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19 | Biotech Hunter | Biotech Hunter